Clinical Trial Update: A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial evaluating carisbamate for essential tremor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• carisbamate (carisbamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Essential Tremor, Movement Disorders | Phase 2 | Status: COMPLETED